Dr. Masahiro Michishita, Chairman & CEO of UMN Pharma, will give a presentation as an invited speaker at Cell Culture Engineering World Asia held in Singapore on June 26 and 27, 2013.
Its title is
“Development of Highly-Purified Recombinant Influenza Vaccine made using Insect Cell Culture System".
